ST
Stemcell Holdings, Inc.
STMM · OTC
$0.06 +0.00% (+$0.00)
Market Cap ¥255.4M
P/E Ratio 0.03x
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/E 0.03x
P/FCF 0.02x
EV/EBITDA 0.38x
Growth
0 /100
Declining EPS growth 26.98%
Book val. growth 15.05%
Rev. growth 11.98%
Profitability
55 /100
Moderate Gross margin 42.91%
Op. margin 9.48%
Net margin 6.81%
Quality
90 /100
Excellent ROIC 15.95%
Asset turnover 1.71x
ROA 11.64%
Debt
92 /100
Low Debt/Equity 0.64x
Net debt/EBITDA 0.36x
Current ratio 2.61x
Stability
75 /100
Stable Beta 0.00x
Profitable years 6
Rev. volatility 1.98%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na STMM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Takaaki Matsuoka
Employees
28
Headquarters
Tokyo